Accueil/Actions/LPTX

LPTX

USD

Leap Therapeutics Inc. Common Stock

$0.404-0.008 (-2.039%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$0.412

Haut

$0.424

Bas

$0.400

Volume

0.26M

Fondamentaux de l'Entreprise

Capitalisation Boursière

22.9M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

3.61M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.222Actuel $0.404Haut $3.92

Actualités Connexes

9 oct. 2025 · 11:00

PR Newswire

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

Leap Therapeutics (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has ...

Leap Therapeutics Announces Closing of $58.88 Million Private Placement in Cash Led by Winklevoss Capital to Initiate a Digital Asset Treasury Strategy

7 oct. 2025 · 13:00

PR Newswire

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

USA News Group News Commentary – Major pharmaceutical companies are unveiling breakthrough cancer data at the European Society for Medical Oncology...